Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5572-5581

  Li, Hao Wei ^a,b   Sachs, Jessica ^a   Pichardo, Clarimel ^a   Bronson, Roderick ^c   Zhao, Guiling ^a,b   Sykes, Megan ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Medicine   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DONOR LYMPHOCYTE INFUSION; DRUG USE; GRAFT VERSUS HOST REACTION; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFECTION PREVENTION; LYMPHOCYTOPENIA; MOUSE; NONALLOREACTIVE T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RISK FACTOR; T CELL DEPLETION; T LYMPHOCYTE;

ANIMALS; CIPROFLOXACIN; GRAFT VS HOST DISEASE; INFLAMMATION; LYMPHOCYTE TRANSFUSION; LYMPHOPENIA; METRONIDAZOLE; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS;

EID: 84871174421     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200045     Document Type: Article

References (74)

1. Pelot, M. R., D. A. Pearson, K. Swenson, G. Zhao, J. Sachs, Y. G. Yang, and M. Sykes. 1999. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cy-clophosphamide- based nonmyeloablative conditioning regimen. Biol. Blood Marrow Transplant. 5: 133-143.
2. Sykes, M., M. A. Sheard, and D. H. Sachs. 1988. Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells. J. Exp. Med. 168: 2391-2396. (Pubitemid 19020917)
3. Chakraverty, R., D. Côté, J. Buchli, P. Cotter, R. Hsu, G. Zhao, T. Sachs, C. M. Pitsillides, R. Bronson, T. Means, et al. 2006. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J. Exp. Med. 203: 2021-2031. (Pubitemid 44188475)
4. Mapara, M. Y., Y. M. Kim, S. P. Wang, R. Bronson, D. H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100: 1903-1909. (Pubitemid 34925172)
5. Mapara, M. Y., Y. M. Kim, J. Marx, and M. Sykes. 2003. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus- leukemia effects after conversion to full donor chimerism. Transplantation 76: 297-305. (Pubitemid 36927988)
6. Sykes, M., Z. Bukhari, and D. H. Sachs. 1989. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant. 4: 465-474. (Pubitemid 19236576)
7. Spitzer, T. R., S. McAfee, R. Sackstein, C. Colby, H. C. Toh, P. Multani, S. Saidman, D. W. Weyouth, F. Preffer, C. Poliquin, et al. 2000. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol. Blood Marrow Transplant. 6(3A): 309-320.
8. Sykes, M., F. Preffer, S. McAfee, S. L. Saidman, D. Weymouth, D. M. Andrews, C. Colby, R. Sackstein, D. H. Sachs, and T. R. Spitzer. 1999. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after nonmyeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet 353: 1755-1759. (Pubitemid 29240375)
9. Bloor, A. J. C., K. Thomson, N. Chowdhry, S. Verfuerth, S. J. Ings, R. Chakraverty, D. C. Linch, A. H. Goldstone, K. S. Peggs, and S. Mackinnon. 2008. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. Biol. Blood Marrow Transplant. 14: 50-58. (Pubitemid 350286737)
10. Spitzer, T. R., S. L. McAfee, B. R. Dey, C. Colby, J. Hope, H. Grossberg, F. Preffer, J. Shaffer, S. I. Alexander, D. H. Sachs, and M. Sykes. 2003. Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation 75: 1748-1751. (Pubitemid 36629162)
11. Heining, C., A. Spyridonidis, E. Bernhardt, J. Schulte-Mönting, D. Behringer, C. Grüllich, A. Jakob, H. Bertz, and J. Finke. 2007. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant. 39: 613-622. (Pubitemid 46729053)
12. Saito, T., Y. Kanda, K. Nakai, S. W. Kim, F. Arima, M. Kami, R. Tanosaki, K. Tobinai, H. Wakasugi, Y. Heike, et al. 2003. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation. Bone Marrow Transplant. 32: 601-608. (Pubitemid 37185096)
13. Weinberg, K., G. Annett, A. Kashyap, C. Lenarsky, S. J. Forman, and R. Parkman. 1995. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol. Blood Marrow Transplant. 1: 18-23.
14. + T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104: 1565-1573.
15. + regulatory T cells suppress lethal acute graft-versushost disease after allogeneic bone marrow transplantation. J. Exp. Med. 196: 389-399.
16. Murali-Krishna, K., and R. Ahmed. 2000. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165: 1733-1737. (Pubitemid 30643121)
17. + T cells: costimulatory requirements and role in memory formation. J. Immunol. 167: 3699-3707.
18. Min, B., H. Yamane, J. Hu-Li, and W. E. Paul. 2005. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174: 6039-6044. (Pubitemid 40663791)
19. Bracci, L., F. Moschella, P. Sestili, V. La Sorsa, M. Valentini, I. Canini, S. Baccarini, S. Maccari, C. Ramoni, F. Belardelli, and E. Proietti. 2007. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. Clin. Cancer Res. 13: 644-653. (Pubitemid 46225372)
20. + T cell anergy and promotes tumor rejection. J. Immunol. 177: 4521-4529.
21. Chang, X., P. Zheng, and Y. Liu. 2008. Homeostatic proliferation in the mice with germline FoxP3 mutation and its contribution to fatal autoimmunity. J. Immunol. 181: 2399-2406.
22. Moxham, V. F., J. Karegli, R. E. Phillips, K. L. Brown, T. T. Tapmeier, R. Hangartner, S. H. Sacks, and W. Wong. 2008. Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J. Immunol. 180: 3910-3918.
23. Miller, J. S., D. J. Weisdorf, L. J. Burns, A. Slungaard, J. E. Wagner, M. R. Verneris, S. Cooley, R. Wangen, S. K. Fautsch, R. Nicklow, et al. 2007. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. Blood 110: 2761-2763. (Pubitemid 47523203)
24. Blazar, B. R., C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor. 2000. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J. Immunol. 165: 4901-4909.
25. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27. (Pubitemid 24035278)
26. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34.
27. Ildstad, S. T., S. M. Wren, J. A. Bluestone, S. A. Barbieri, and D. H. Sachs. 1985. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162: 231-244. (Pubitemid 15029899)
28. Zhao, Y., J. I. Rodriguez-Barbosa, K. Swenson, G. Zhao, J. S. Arn, and M. Sykes. 2001. Highly disparate xenogeneic skin graft tolerance induction by fetal pig thymus in thymectomized mice: conditioning requirements and the role of coimplantation of fetal pig liver. Transplantation 72: 1608-1615. (Pubitemid 33096733)
29. + cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects. Blood 83: 2560-2569.
30. Sykes, M., V. S. Abraham, M. W. Harty, and D. A. Pearson. 1993. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J. Immunol. 150: 197-205. (Pubitemid 23069796)
31. Tomita, Y., D. H. Sachs, A. Khan, and M. Sykes. 1996. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61: 469-477.
32. Brandon, J. A., C. D. Jennings, A. M. Kaplan, and J. S. Bryson. 2011. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy. J. Immunol. 186: 3726-3734.
33. Sandau, M. M., C. J. Winstead, and S. C. Jameson. 2007. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J. Immunol. 179: 120-125. (Pubitemid 46986525)
34. Surh, C. D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 29: 848-862.
35. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737. (Pubitemid 32678096)
36. Gattinoni, L., S. E. Finkelstein, C. A. Klebanoff, P. A. Antony, D. C. Palmer, P. J. Spiess, L. N. Hwang, Z. Yu, C. Wrzesinski, D. M. Heimann, et al. 2005. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J. Exp. Med. 202: 907-912. (Pubitemid 41396891)
37. Klebanoff, C. A., H. T. Khong, P. A. Antony, D. C. Palmer, and N. P. Restifo. 2005. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol. 26: 111-117.
38. Wang, L. X., R. Li, G. Yang, M. Lim, A. O'Hara, Y. Chu, B. A. Fox, N. P. Restifo, W. J. Urba, and H. M. Hu. 2005. Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing. Cancer Res. 65: 10569-10577. (Pubitemid 41743752)
39. Chung, B., E. P. Dudl, D. Min, L. Barsky, N. Smiley, and K. I. Weinberg. 2007. Prevention of graft-versus-host disease by anti IL-7Rα antibody. Blood 110: 2803-2810. (Pubitemid 350006932)
40. Chung, B., E. Dudl, A. Toyama, L. Barsky, and K. I. Weinberg. 2008. Importance of interleukin-7 in the development of experimental graft-versus-host disease. Biol. Blood Marrow Transplant. 14: 16-27. (Pubitemid 350286739)
41. Gendelman, M., T. Hecht, B. Logan, S. Vodanovic-Jankovic, R. Komorowski, and W. R. Drobyski. 2004. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J. Immunol. 172: 3328-3336. (Pubitemid 38263725)
42. Alpdogan, O., J. M. Eng, S. J. Muriglan, L. M. Willis, V. M. Hubbard, K. H. Tjoe, T. H. Terwey, A. Kochman, and M. R. M. van den Brink. 2005. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 105: 865-873. (Pubitemid 40070777)
43. Miyagawa, F., Y. Tagaya, B. S. Kim, H. J. Patel, K. Ishida, T. Ohteki, T. A. Waldmann, and S. I. Katz. 2008. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J. Immunol. 181: 1109-1119.
44. Roychowdhury, S., B. W. Blaser, A. G. Freud, K. Katz, D. Bhatt, A. K. Ferketich, V. Bergdall, D. Kusewitt, R. A. Baiocchi, and M. A. Caligiuri. 2005. IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood 106: 2433-2435. (Pubitemid 41510817)
45. Kieper, W. C., A. Troy, J. T. Burghardt, C. Ramsey, J. Y. Lee, H. Q. Jiang, W. Dummer, H. Shen, J. J. Cebra, and C. D. Surh. 2005. Cutting edge: recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174: 3158-3163. (Pubitemid 40354015)
46. + immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol. Blood Marrow Transplant. 8: 525-535.
47. + regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 110: 1689-1697.
48. Murphy, K. M., C. A. Nelson, and J. R. Sedý . 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6: 671-681. (Pubitemid 44298216)
49. Cooke, K. R., A. Gerbitz, J. M. Crawford, T. Teshima, G. R. Hill, A. Tesolin, D. P. Rossignol, and J. L. M. Ferrara. 2001. LPS antagonism reduces graft-versus- host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J. Clin. Invest. 107: 1581-1589. (Pubitemid 32574644)
50. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. M. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213. (Pubitemid 27444217)
51. Hill, G. R., and J. L. M. Ferrara. 2000. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95: 2754-2759. (Pubitemid 30235880)
52. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371. (Pubitemid 44924494)
53. Lee, P. I., E. J. Ciccone, S. W. Read, A. Asher, R. Pitts, D. C. Douek, J. M. Brenchley, and I. Sereti. 2009. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J. Infect. Dis. 199: 1664-1670.
54. Bourgeois, C., Z. Hao, K. Rajewsky, A. J. Potocnik, and B. Stockinger. 2008. Ablation of thymic export causes accelerated decay of naive CD4 T cells in the periphery because of activation by environmental antigen. Proc. Natl. Acad. Sci. USA 105: 8691-8696. (Pubitemid 351987742)
55. Owens, W. E., and R. D. Berg. 1980. Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice. Infect. Immun. 27: 461-467. (Pubitemid 10144938)
56. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415. (Pubitemid 29343964)
57. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992. (Pubitemid 39273741)
58. + graft-versus-host- reactive effector cells. J. Immunol. 181: 6820-6828.
59. Ichinohe, T., I. K. Pang, Y. Kumamoto, D. R. Peaper, J. H. Ho, T. S. Murray, and A. Iwasaki. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 108: 5354-5359.
60. Gibbert, K., K. K. Dietze, G. Zelinskyy, K. S. Lang, W. Barchet, C. J. Kirschning, and U. Dittmer. 2010. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virusspecific T cells and prevents virus-induced disease. J. Immunol. 185: 6179-6189.
61. + T cells contribute to the exacerbation of class I MHC disparate graft-vs-host reaction by concurrent murine cytomegalovirus infection. Clin. Immunol. Immunopathol. 67: 84-90.
62. El-Amouri, I. S., M. Bani-Ahmad, Y. Tang-Feldman, F. Lin, C. Ko, C. Pomeroy, and O. R. Oakley. 2010. Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression. Clin. Exp. Immunol. 162: 379-391.
63. Hossain, M. S., J. D. Roback, F. Wang, and E. K. Waller. 2008. Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection. J. Immunol. 180: 6892-6902.
64. Kinnier, C. V., T. Martinu, K. M. Gowdy, J. L. Nugent, F. L. Kelly, and S. M. Palmer. 2011. Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant. Transpl. Immunol. 24: 83-93.
65. Roback, J. D., M. S. Hossain, L. Lezhava, J. W. Gorechlad, S. A. Alexander, D. L. Jaye, S. Mittelstaedt, S. Talib, J. E. Hearst, C. D. Hillyer, and E. K. Waller. 2003. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. J. Immunol. 171: 6023-6031. (Pubitemid 37467221)
66. Via, C. S., J. D. Shanley, and G. M. Shearer. 1990. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only: analysis of in vitro T cell function. J. Immunol. 145: 3283-3289.
67. Olkinuora, H., E. von Willebrand, J. M. Kantele, O. Vainio, K. Talvensaari, U. Saarinen-Pihkala, S. Siitonen, and K. Vettenranta. 2011. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation. Scand. J. Immunol. 73: 586-593.
68. Versluys, A. B., J. W. A. Rossen, B. van Ewijk, R. Schuurman, M. B. Bierings, and J. J. Boelens. 2010. Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of lifethreatening acute and chronic alloimmune lung syndromes. Biol. Blood Marrow Transplant. 16: 782-791.
69. Goldberg, G. L., C. G. King, R. A. Nejat, D. Y. Suh, O. M. Smith, J. C. Bretz, R. M. Samstein, J. A. Dudakov, A. P. Chidgey, S. Chen-Kiang, et al. 2009. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J. Immunol. 182: 5846-5854.
70. Jenq, R. R., C. G. King, C. Volk, D. Suh, O. M. Smith, U. K. Rao, N. L. Yim, A. M. Holland, S. X. Lu, J. L. Zakrzewski, et al. 2009. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood 113: 1574-1580.
71. Kelly, R. M., S. L. Highfill, A. Panoskaltsis-Mortari, P. A. Taylor, R. L. Boyd, G. A. Hollander, and B. R. Blazar. 2008. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimeninduced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 111: 5734-5744.
72. Kenins, L., J. W. Gill, R. L. Boyd, G. A. Holländer, and A. Wodnar-Filipowicz. 2008. Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation. J. Exp. Med. 205: 523-531. (Pubitemid 351439300)
73. Min, D., P. A. Taylor, A. Panoskaltsis-Mortari, B. Chung, D. M. Danilenko, C. Farrell, D. L. Lacey, B. R. Blazar, and K. I. Weinberg. 2002. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99: 4592-4600. (Pubitemid 34627232)
74. Solomon, S. R., S. Mielke, B. N. Savani, A. Montero, L. Wisch, R. Childs, N. Hensel, J. Schindler, V. Ghetie, S. F. Leitman, et al. 2005. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 106: 1123-1129. (Pubitemid 41076463)